tiprankstipranks
Trending News
More News >

Martine Rothblatt Insider Profile

4 Followers
Martine Rothblatt, Chairperson & CEO, Director at United Therapeutics, holds 1.07K shares in BETA Technologies, Inc. Class A (Ticker: BETA), holds 639.49K shares in United Therapeutics (Ticker: UTHR).
tipranks
Martine Rothblatt

Martine Rothblatt
United Therapeutics (UTHR)
Chairperson & CEO, Director

Ranked #55,663 out of 105,518 Corporate Insiders

Profitable Transactions

50%
7 out of 14 Profitable Transactions

Average Return

-0.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$309M
99.99%
<0.01%
A breakdown of Martine Rothblatt's holdings

Insider Roles

United Therapeutics
(UTHR)
Chairperson & CEO, Director
BETA Technologies, Inc. Class A
(BETA)
Director
Roles that Martine Rothblatt holds in companies

Most Profitable Insider Trade

Stock:
United Therapeutics
(UTHR)
Rating:Informative Sell
Date:Jun 03, 2015 - Jun 03, 2016
Return:+36.70%
The most profitable trade made by Martine Rothblatt

Martine Rothblatt's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
United Therapeutics
Dec 19, 2025
Chairperson & CEO, Director
Uninformative Buy
1.20M
$308.61M
BETA Technologies, Inc. Class A
Feb 03, 2026
Director
Uninformative Buy
$19.30K
List of latest transactions for each holding click on a transaction to see Martine Rothblatt's performance on stock

Martine Rothblatt insider profile FAQ

What is the percentage of profitable transactions made by Martine Rothblatt?
The percentage of profitable transactions made by Martine Rothblatt is 50%.
    What is the average return per transaction made by Martine Rothblatt?
    The average return per transaction made by Martine Rothblatt is -0.80%.
      What stocks does Martine Rothblatt hold?
      Martine Rothblatt holds: UTHR, BETA stocks.
        What was Martine Rothblatt’s latest transaction?
        Martine Rothblatt latest transaction was an Uninformative Buy of ―.
          What was Martine Rothblatt's most profitable transaction?
          Martine Rothblatt’s most profitable transaction was an Informative Sell of UTHR stock on June 3, 2015. The return on the trade was 36.70%.
            What is Martine Rothblatt's role in United Therapeutics?
            Martine Rothblatt's role in United Therapeutics is Chairperson & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.